Cellworks Omics Biology Model (CBM) to predict therapy response and identify novel biomarkers for 5FU-based combination therapy in gastric cancer patients.

Michael Castro,Ansu Kumar,Himanshu Grover,Vivek Patil,Ashish Kumar Agrawal,Anuj Tyagi,Humera Azam,Karthik Sundara Raju,Poornachandra G,Yuvavani Velkuru,Nirjhar Mundkur,Vishwas Joseph,Pallavi Kumari,Vijayashree P S,Naga Ganesh,Yashaswini Ullal,Yugandhara Narvekar,Annapoorna Prakash,Adity Ghosh

Cellworks Omics Biology Model (CBM) to predict therapy response and identify novel biomarkers for 5FU-based combination therapy in gastric cancer patients.

2021

Michael Castro
Ansu Kumar
Himanshu Grover
Vivek Patil
Ashish Kumar Agrawal
Anuj Tyagi
Humera Azam
Karthik Sundara Raju
Poornachandra G
Yuvavani Velkuru
Nirjhar Mundkur
Vishwas Joseph
Pallavi Kumari
Vijayashree P S
Naga Ganesh
Yashaswini Ullal
Yugandhara Narvekar
Annapoorna Prakash
Adity Ghosh

e16091Background: Using a 5FU backbone, a variety of combination chemotherapy regimens have been adopted for gastric cancer. However, the genetic heterogeneity of the disease suggests certain drugs...

Keywords:

combination chemotherapy
Combination therapy
therapy response
Medicine
Genetic heterogeneity
Disease
Bioinformatics
Omics
Cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations